Czech National Bank Raises Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Czech National Bank raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 7.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,707 shares of the biotechnology company's stock after purchasing an additional 1,082 shares during the quarter. Czech National Bank's holdings in Axon Enterprise were worth $9,335,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Groupama Asset Managment purchased a new position in Axon Enterprise in the third quarter valued at $200,000. Massachusetts Financial Services Co. MA acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $120,553,000. International Assets Investment Management LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at about $871,860,000. Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Finally, 1832 Asset Management L.P. increased its stake in shares of Axon Enterprise by 44.0% during the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company's stock worth $110,546,000 after buying an additional 114,800 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a research note on Wednesday, October 23rd. JMP Securities boosted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a research note on Thursday, October 31st. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research report on Monday, November 11th. Finally, Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $504.92.

Axon Enterprise Stock Performance

Shares of AXON traded up $0.20 during mid-day trading on Wednesday, reaching $580.00. 701,948 shares of the company's stock were exchanged, compared to its average volume of 689,837. The business's fifty day simple moving average is $612.80 and its 200-day simple moving average is $454.94. Axon Enterprise, Inc. has a 52-week low of $246.99 and a 52-week high of $698.67. The stock has a market capitalization of $44.23 billion, a PE ratio of 149.87, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insiders Place Their Bets

In related news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company's stock, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company's stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now owns 154,394 shares of the company's stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock valued at $30,721,337. Insiders own 6.10% of the company's stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.